Product Extends the Functionality of Progenesis QI for Proteomics
MILFORD, Mass.--(BUSINESS WIRE)--Mar. 15, 2017--
Waters Corporation (NYSE:WAT) announced that it will now offer Proteolabels,
a new software that has been designed as an extension for Progenesis®
QI for proteomics users and researchers. Proteolabels supports
studies involving stable isotope labels, such as “SILAC” and dimethyl
labeling in duplex or triplex. Waters®
is offering Proteolabels through an exclusive agreement with Omic
Analytics, an innovative start-up based in Liverpool, UK.
“Waters takes great pride in working with innovative research groups
like Omic Analytics to develop effective solutions to solve customer
needs,” said Dr. Steve Smith, Vice President Informatics at Waters.
“Proteolabels extends the use of Progenesis QI for proteomics, a need
for many of our customers working in health sciences, along with a
growing number in food and environmental research.”
Proteolabels was engineered with a focus on performance and usability,
empowering scientists to explore their data and achieve high-quality
results. Features include:
Co-detection: The workflow builds upon the Progenesis QI for
proteomics co-detection feature, in which features are aligned across
LC-MS runs to improve sensitivity and reproducibility.
Auto-detect: Proteolabels makes a first pass through the data
to suggest optimal parameters, simplifying the analysis.
Peptide scoring: Proteolabels contains novel metrics for
scoring the quality of pairs/triples detected, enabling users to
measure the reliability of quantitation down to the level of each
Intelligent protein inference: Intelligent weighted averaging
of different peptide-level signals is performed, to give more accurate
protein-level quantitation results.
QC metrics: Proteolabels contains a large number of QC metrics
and data plotting options, enabling users to interact and explore
their data, and, where needed, make decisions as to how arrive at the
best protein set.
“At Omic Analytics, we are very excited to be collaborating with Waters
on this new venture. We look forward to seeing Proteolabels in action
with scientists all over the world,” said Prof Andy Jones, Director of
Omic Analytics Ltd, UK.
More information about Proteolabels will be available during a live
webinar on March 28, 2017 at 10:00 am EDT.
About Waters Corporation (www.waters.com)
Corporation (NYSE: WAT) develops and manufactures advanced analytical
science technologies for laboratory-dependent organizations. For more
than 50 years, the Company has pioneered a connected portfolio of
separations science, laboratory information management, mass
spectrometry and thermal analysis systems.
About Omic Analytics Ltd (http://www.omicanalytics.com)
Analytics is an innovative start-up, based in Liverpool, UK, focusing on
cutting-edge products and services in computational biology – including
multi-omic data integration, knowledge management and systems biology.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170315005032/en/
Source: Waters Corporation
Chris Orlando, 508-482-2623